In addition, SOX9 expression was reciprocally exclusive with several tumor immune checkpoints, such as CD27, CTLA4, LAG3, TIGIT, IL10, CSF1R, ADORA2A, CD244, etc. (Figure 6B; Supplementary Table 2). This evidence concerns the gene TIGIT and neoplasm.